Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
A. David Rothner, MD, is Chairman Emeritus of the Section of Child Neurology and Director of the Pediatric/Adolescent Headache Program at Cleveland Clinic. He also directs the Patient Education Program in the Division of Education.
Dr. Rothner received his medical degree from the University of Illinois College of Medicine. Following completion of an internship and junior residency in pediatrics at the Presbyterian-St. Luke’s Hospital in Chicago, he completed a senior residency in pediatrics at Columbia Presbyterian Medical Center’s Babies Hospital in New York City. Dr. Rothner continued his training at the Neurologic Institute of Columbia Presbyterian Medical Center with a fellowship in pediatric neurology. He has been a member of the faculty in the Department of Pediatrics and Neurology at Cleveland Clinic since 1973.
Currently, Dr. Rothner is the Chairman Emeritus of the Section of Child Neurology at Cleveland Clinic. He is also Vice-Chairman of the Division of Education. He serves as a Fellow of the American Academies of Pediatrics and Neurology, and has served on the advisory boards of the Epilepsy Foundation of America and the March of Dimes. Dr. Rothner directs the Pediatric/Adolescent Headache Program and also directs the efforts of the Patient Education Program.
Dr. Rothner sits on the editorial board of Pediatrics Today and Headache Quarterly. He has published over 250 original articles, book chapters, tapes and reviews in the areas of epilepsy, headaches in children and general pediatric neurology. He is Co-Editor of the textbook, Headache in Children and Adolescents.
general pediatric neurology, Headaches, Neurofibromatosis
Innovations & Patents
Developed Pediatric/Adolescent Chronic Pain Rehabilitation Program
Developed Pediatric/Adolescent Headache Fellowship
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/2/2014, Dr. Rothner has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.